7.66
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
What drives Emergent BioSolutions Inc. stock priceHigh-velocity capital appreciation - Autocar Professional
Is Emergent BioSolutions Inc. a good long term investmentFree Market Dynamics Reports - jammulinksnews.com
Emergent BioSolutions Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
Is MDU Resources Group Inc. a good long term investmentHigh-yield investments - jammulinksnews.com
AGYS Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
What analysts say about Emergent BioSolutions Inc. stockFree Investment Community - jammulinksnews.com
Hawthorn Bancshares Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com
What drives EMX Royalty Corporation stock priceSkyrocketing returns - jammulinksnews.com
Emergent Signs $174M Manufacturing Deal For AstraZeneca’s Covid-19 Candidate - TipRanks
What makes Emergent BioSolutions Inc. stock price move sharplyPotential Rocket List - beatles.ru
Lobbying Update: $440,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed - Quiver Quantitative
Emergent BioSolutions to Report Second Quarter 2025 Financial Re - GuruFocus
Emergent BioSolutions Inc. to Host Q2 2025 Financial Results Conference Call on August 6 - Nasdaq
Emergent BioSolutions Q2 2025 Earnings Call Scheduled for August 6: Key Details Inside - Stock Titan
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025 - TradingView
Government Contract Update: $52M payment to EMERGENT BIOSOLUTIONS CANADA INC - Nasdaq
Emergent BioSolutions signs contract modification award for CNJ-016 - MSN
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Emergent BioSolutions stock rises on government contract modification - Investing.com India
Emergent BioSolutions Stock Rises After New US Order For Smallpox Complication Therapy - Stocktwits
Emergent BioSolutions secures contract modification for smallpox treatment By Investing.com - Investing.com South Africa
Emergent BioSolutions secures contract modification for smallpox treatment - Investing.com Australia
Emergent BioSolutions (EBS) Expands Smallpox Vaccine Contract wi - GuruFocus
Emergent BioSolutions (EBS) Secures Smallpox Preparedness Contra - GuruFocus
Emergent BioSolutions Gets $51.9 Million Contract Modification for Smallpox Preparedness - MarketScreener
Emergent BioSolutions stock rises on government contract modification By Investing.com - Investing.com Canada
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts - The Manila Times
Emergent BioSolutions Secures Contract Modification for Additional VIGIV Doses to Support U.S. Smallpox Preparedness - Quiver Quantitative
Emergent BioSolutions Strengthens US Biodefense Arsenal with $51.9M Government Contract - Stock Titan
Lobbying Update: $40,000 of EMERGENT BIOSOLUTIONS lobbying was just disclosed - Quiver Quantitative
Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - simplywall.st
Emergent BioSolutions adds KLOXXADO to online naloxone platform By Investing.com - Investing.com India
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® ( - GuruFocus
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate - The Manila Times
Investors Can Still File Late Claims in Emergent BioSolutions Settlement - TradingView
Emergent BioSolutions Inc.(NYSE: EBS) added to Russell 3000E Value Index - MarketScreener
Is Emergent BioSolutions, Inc. overvalued or undervalued? - MarketsMojo
Emergent BioSolutions secures $62.4 million contract for botulism antitoxin By Investing.com - Investing.com South Africa
Emergent BioSolutions Awarded $62.4 Million Contract Modification for BAT® Antitoxin by U.S. Department of Health and Human Services - Quiver Quantitative
Emergent BioSolutions Announces Addition to Russell 3000® Index - The Manila Times
Emergent BioSolutions to join Russell 3000 Index after market close June 27 - Investing.com
EBS Stock Up 1.4% after 1-Day Win Streak - Trefis
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):